小鼠模型技术市场－全球产业规模、份额、趋势、机会和预测，依技术、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球小鼠模型技术市场规模为13.5亿美元，预计2030年将以10.3%的复合年增长率成长至24.3亿美元。小鼠模型技术涵盖基因改造或近交系小鼠的开发、生产和应用，作为生物医学研究、药物发现和毒理学研究的体内工具。推动该市场成长的关键因素包括製药和生物技术领域研发投入的增加、对个人化医疗方法日益增长的需求，以及CRISPR/Cas9等基因工程技术的不断进步，这些技术能够实现更精准的疾病建模。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球小鼠模型技术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依技术分类（CRISPR基因敲除、随机插入、大片段标靶插入、ES细胞修饰（同源重组）及其他）
  • 按最终用户划分（製药公司、生物技术公司、学术和研究机构、合约研究和生产组织）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美小鼠模型技术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲小鼠模型技术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区小鼠模型技术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲小鼠模型技术市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲小鼠模型技术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球小鼠模型技术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Biocytogen LLC
• Charles River Laboratories Inc.
• Cyagen Biosciences
• GemPharmatech Co Ltd.
• genOway SA
• Ingenious Targeting Laboratory Inc.
• Merck KGaA.
• Ozgene Pty Ltd.
• Taconic Biosciences Inc.
• Polygena AG

第十六章：策略建议

第17章调查会社について・免责事项

The Global Mice Model Technologies Market, valued at USD 1.35 Billion in 2024, is projected to experience a CAGR of 10.3% to reach USD 2.43 Billion by 2030. Mice model technologies encompass the development, production, and application of genetically modified or inbred mouse strains as *in vivo* tools for biomedical research, drug discovery, and toxicology studies. Key drivers supporting this market's growth include increasing research and development investments within the pharmaceutical and biotechnology sectors, the rising demand for personalized medicine approaches, and continuous advancements in genetic engineering techniques such as CRISPR/Cas9, which enable more precise disease modeling.

Key Market Drivers

The escalating global prevalence of chronic diseases acts as a primary catalyst for growth within the mice model technologies market. Conditions such as cancer, diabetes, and neurological disorders necessitate extensive research to elucidate pathogenesis, identify therapeutic targets, and develop effective treatments. Mice models are indispensable tools, providing physiologically relevant *in vivo* systems for disease modeling and drug efficacy testing. The increased burden of these diseases drives demand for specialized mouse models that accurately recapitulate human disease phenotypes. For instance, according to the National Cancer Institute, in an article dated April 4, 2024, "Fiscal Year 2024 Appropriation - NCI", the total appropriation for NCI in fiscal year 2024 was $7.22 billion for cancer research, fueling the application of advanced mouse models crucial for oncology investigations.

Key Market Challenges

A significant challenge impeding the growth of the Global Mice Model Technologies Market is the stringent ethical considerations and regulatory frameworks governing animal welfare in research. These frameworks impose substantial administrative burdens and increased operational costs on research institutions and pharmaceutical companies involved in developing and utilizing mouse models. Navigating complex approval processes for animal studies can extend timelines for drug discovery and toxicology assessments, thereby slowing the development and application of new mouse models.

Key Market Trends

The increasing development of humanized mice models is a significant trend, driven by the need for preclinical tools that more closely mimic human physiology and disease. These models enhance the translational relevance of drug discovery and development, especially in oncology, immunology, and infectious diseases. Charles River Laboratories, in December 2023, highlighted advancements in next-generation humanized models through CRISPR-mediated genetic modification, expanding their utility for immuno-oncology research.

Key Market Players

• Biocytogen LLC
• Charles River Laboratories Inc.
• Cyagen Biosciences
• GemPharmatech Co Ltd.
• genOway S.A.
• Ingenious Targeting Laboratory Inc.
• Merck KGaA.
• Ozgene Pty Ltd.
• Taconic Biosciences Inc.
• Polygena AG

Report Scope:

In this report, the Global Mice Model Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mice Model Technologies Market, By Technology:

• CRISPR Knockout
• Random Insertions
• Large and Targeted Insertions
• ES Cell Modification (Homologous Recombination)
• Others

Mice Model Technologies Market, By End Users:

• Pharmaceutical Companies
• Biotechnology Companies
• Academic and Research Facilities
• Contract Research and Manufacturing Organizations

Mice Model Technologies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Mice Model Technologies Market.

Available Customizations:

Global Mice Model Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Mice Model Technologies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (CRISPR Knockout, Random Insertions, Large and Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)
  • 5.2.2. By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Mice Model Technologies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By End Users
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Mice Model Technologies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By End Users
  • 6.3.2. Canada Mice Model Technologies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By End Users
  • 6.3.3. Mexico Mice Model Technologies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By End Users

7. Europe Mice Model Technologies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By End Users
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Mice Model Technologies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By End Users
  • 7.3.2. France Mice Model Technologies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By End Users
  • 7.3.3. United Kingdom Mice Model Technologies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By End Users
  • 7.3.4. Italy Mice Model Technologies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By End Users
  • 7.3.5. Spain Mice Model Technologies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By End Users

8. Asia Pacific Mice Model Technologies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By End Users
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Mice Model Technologies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By End Users
  • 8.3.2. India Mice Model Technologies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By End Users
  • 8.3.3. Japan Mice Model Technologies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By End Users
  • 8.3.4. South Korea Mice Model Technologies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By End Users
  • 8.3.5. Australia Mice Model Technologies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By End Users

9. Middle East & Africa Mice Model Technologies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By End Users
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Mice Model Technologies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By End Users
  • 9.3.2. UAE Mice Model Technologies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By End Users
  • 9.3.3. South Africa Mice Model Technologies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By End Users

10. South America Mice Model Technologies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By End Users
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Mice Model Technologies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By End Users
  • 10.3.2. Colombia Mice Model Technologies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By End Users
  • 10.3.3. Argentina Mice Model Technologies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By End Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Mice Model Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Biocytogen LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Charles River Laboratories Inc.
• 15.3. Cyagen Biosciences
• 15.4. GemPharmatech Co Ltd.
• 15.5. genOway S.A.
• 15.6. Ingenious Targeting Laboratory Inc.
• 15.7. Merck KGaA.
• 15.8. Ozgene Pty Ltd.
• 15.9. Taconic Biosciences Inc.
• 15.10. Polygena AG

16. Strategic Recommendations

17. About Us & Disclaimer